Meant to include this one earlier, brought to our attention from our friends over at PathologyBlawg.com
A chain of opiate addiction recovery centers, headquartered in Harrodsburg, Ky., and a Russell Springs, Ky., clinical laboratory, along with two physician owners, agreed to pay the U.S. Government millions of dollars to resolve civil allegations that they fraudulently billed federal health care programs for medically unnecessary and excessive urine tests.
Strangely, DOJ and the states Attorney Generals don¹t see to be concerned about the same abuse in the private insurance sector.
However, something to chew on – are medical plans obtained through the Federal Healthcare Exchange (or a state exchange) elevated to a federal health care program. I assume the answer is “no” as a mere result of legal definition, but we will wait and see.
Still, the fox appears to be the only one watching the hen house.
Check out these articles:
Kentucky Addiction Treatment Center, Clinical Laboratory and Two Physician Owners to Pay $15.75 Million to Resolve Allegations of Fraudulent Urine Drug Testing
Attorney states cash kickbacks from urine drug screen lab are perfectly legal
Blue Cross Accuses Drug Test Co. Of $36M Fraud Scheme
An excellent article just sent to me by someone I have come to consider a friend:
It¹s impossible to know what led Hoffman to start using after so many years of sobriety. After he opened a portal to that vortex of chemical relief, however, it doesn’t surprise me at all that he couldn¹t heave himself out in time to save his life.
New York Times just released an excellent series of articles that attempts to dial in on answering this question.
You can read those articles here.
The FDA defied its own experts to approve a new prescription narcotic in a form almost certain to cause addiction and death from overdoses.
On October 26 the savvy investor’s website SeekingAlpha.com published the following remarkable comment about a new and highly addictive painkiller called Zohydro ER, which only the previous day had been approved for sale by the U.S. Food and Drug Administration despite consistent warnings – including from the FDA’s official advisory panel – that Z is potentially more addictive and dangerous than its sister opiate drug, the original and deadly OxyContin.
The full article can be read here: